Yazar Lab
Yazar Lab
  • Home
  • About
  • Services
  • Publications
  • Blog
  • Contact
  • More
    • Home
    • About
    • Services
    • Publications
    • Blog
    • Contact
  • Home
  • About
  • Services
  • Publications
  • Blog
  • Contact

Publications

Hot Air Balloons in Cappadocia, Turkey

MDMA Clinical Development


  • Mitchell JM, Yazar-Klosinski B, Lilienstein A, Mithoefer M, Nicholas C, Nielson E, Paleos C, Thomas C.  (in press). MDMA-Assisted Therapy for Treatment of PTSD. In Aaronson ST, Garcia-Romeu A, Suppes T. (Eds.), Psychedelics: Transforming Psychiatry. The American Psychiatric Association Publishing. 
  • Mitchell, J. M., Ot'alora G, M., van der Kolk, B., Shannon, S., Bogenschutz, M., Gelfand, Y., Paleos, C., Nicholas, C. R., Quevedo, S., Balliett, B., Hamilton, S., Mithoefer, M., Kleiman, S., Parker-Guilbert, K., Tzarfaty, K., Harrison, C., de Boer, A., Doblin, R., Yazar-Klosinski, B., & MAPP2 Study Collaborator Group (2023). MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nature Medicine, 29(10), 2473–2480. Author Correction: Nature Medicine 2024 Nov;30(11):3382 
  • Mitchell J.M., Bogenschutz, M., Lilienstein, A., et al. (2021) MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine. 27(6):1025-1033
  • Mitchell, J., Coker, A., & Yazar-Klosinski, B. (2021). Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy. Nature Medicine. 27(10): 1691–1692 
  • van der Kolk BA, Wang JB, Yehuda R, Bedrosian L, Coker AR, Harrison C, Mithoefer M, Yazar-Klosinki B, Emerson A, Doblin R. (2024) Effects of MDMA-assisted therapy for PTSD on self-experience. PLoS One. 2024 Jan 10;19(1):e0295926
  • Nicholas, C. R., Wang, J. B., Coker, A., Mitchell, J. M., Klaire, S. S., Yazar-Klosinski, B., Emerson, A., Brown, R. T., & Doblin, R. (2022). The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD. Drug and Alcohol Dependence, 233: 109356 
  • Ching, T. H., Williams, M. T., Wang, J. B., Jerome, L., Yazar-Klosinski, B., Emerson, A., & Doblin, R. (2022). MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial. Journal of Psychopharmacology, 36(8): 974–986 
  • Wang, J. B., Lin, J., Bedrosian, L., Coker, A., Jerome, I., Feduccia, A., Lilienstein, A., Harrison, C., Heimler, E., Mithoefer, M., Mithoefer, A., Ot’alora G., M., Poulter, B., Carlin, S., Matthews, R., Yazar-Klosinski, B., Emerson, A., & Doblin, R. (2021). Scaling Up: Multisite Open-Label Clinical Trials of MDMA-Assisted Therapy for Severe Posttraumatic Stress Disorder. Journal of Humanistic Psychology, 0(0)
  • Ponte L, Jerome, L., Hamilton, S., Mithoefer, M. C., Yazar-Klosinski, B. B., Vermetten, E., & Feduccia, A. A. (2021) Sleep Quality Improvements after MDMA-assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder. J Traumatic Stress. 2021 Aug;34(4):851-863. Epub 2021 Jun 10. Correction published: J Trauma Stress. 2024 Dec 3. doi: 10.1002/jts.23098
  • Gorman I, Belser AB, Jerome L, Hennigan C, Shechet B, Hamilton S, Yazar-Klosinski B, Emerson A, Feduccia AA. (2020) Posttraumatic Growth After MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder. Journal of Traumatic Stress. 33(2):161-170. Correction published: J Trauma Stress. 2024 Dec 3. doi: 10.1002/jts.23097
  • Feduccia AA, Jerome L, Yazar-Klosinski, Emerson A, Mithoefer MC. (2019) Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-assisted Psychotherapy Compared to Paroxetine and Sertraline. Frontiers in Psychiatry. 10:650
  • Ot'alora, G, M., Grigsby, J., Poulter, B., Van Derveer, J. W., Giron, S. G., Jerome, L., Feduccia, A., Hamilton, S., Yazar-Klosinski, B., Emerson, A., Mithoefer, M., Doblin, R. (2018) 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial. Journal of Psychopharmacology. 32(12):1295-1307
  • Mithoefer MC,  Mithoefer A, Feduccia A, Jerome L, Wagner M, Wymer J, Holland J, Hamilton S, Yazar-Klosinski B, Emerson A, Doblin R. (2018) 3-4 methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomized, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry. 5(6): 486-497
  • Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski BB, Michel Y, Brewerton TD, Doblin R. (2013) Durability of Improvement in Post-traumatic Stress Disorder Symptoms and Absence of Harmful Effects or Drug Dependency after 3,4- Methylenedioxymethamphetamine-assisted Psychotherapy: A Prospective Long-term Follow-up Study. Journal of Psychopharmacology 27(1):28-39
  • Christie, D., Yazar-Klosinski, B., Nosova, E., Kryskow, P., Siu, W., Lessor, D., & Argento, E. (2022). MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder. Frontiers in Psychiatry, 13: 939302 
  • Wolfson P, Andries J, Feduccia A, Jerome L, Williams E, Carlin S, Sola E, Wang J, Hamilton S, Yazar-Klosinski B, Emerson A, Mithoefer M, Doblin R. (2020) MDMA-assisted Psychotherapy for Treatment of Anxiety and Other Psychological Distress Related to Life-Threatening Illnesses: A Randomized Pilot Study. Scientific Reports. 10(1): 20442
  • Monson CM, Wagner AC, Mithoefer AT, Liebman RE, Feduccia AA, Jerome LI, Yazar-Klosinski B, Emerson A, Doblin R & Mithoefer MC (2020) MDMA-facilitated cognitive-behavioral conjoint therapy for posttraumatic stress disorder: An uncontrolled trial. European Journal of Psychotraumatology. 11(1): 1840123
  • Danforth Al, Grob CS, Struble C, Feduccia AA, Walker N, Jerome L, Yazar-Klosinski B, Emerson A. (2018) Reduction in Social Anxiety After MDMA-assisted psychotherapy with Autistic Adults: a Randomized, Double-Blind, Placebo-Controlled Pilot Study. Psychopharmacology. 235(11):3137-3148 
  • Danforth A, Struble CM, Yazar-Klosinski BB, Grob CS. (2016) MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults. Prog Neuropsychopharmacology Biological Psychiatry 64: 237- 249
  • Yazar-Klosinski BB, Mithoefer MC. (2017) Potential psychiatric uses for MDMA. Clinical Pharmacology and Therapeutics. 101(2): 194-196
  • Jerome L, Schuster S, Yazar-Klosinski BB. (2013) Can MDMA Play a Role in the Treatment of Substance Abuse? Current Drug Abuse Reviews. 6: 54-62


Toxicology & Pharmacology


  • Huestis MA, Smith WB, Leonowens C, Blanchard R, Viaccoz A, Spargo E, Miner NB, Yazar-Klosinski B. MDMA pharmacokinetics: A population and physiologically based pharmacokinetics model-informed analysis. CPT Pharmacometrics Syst Pharmacol. 2025 Feb;14(2):376-388
  • Cohen, I. V., Barber, L., Dubnicka, T. P., Hurtado, S. B., Tincher, S. A., Stankowski, L. F., Jr, & Yazar-Klosinski, B. (2021). Three regulatory compliant test systems show no signs of MDMA-related genotoxicity. Journal of Psychopharmacology, 35(11): 1431–1434 


Chemistry, Manufacturing & Controls

  • Nair, J. B., Hakes, L., Yazar-Klosinski, B., & Paisner, K. (2021). Fully Validated, Multi-Kilogram cGMP Synthesis of MDMA. ACS Omega, 7(1): 900–907 


Health Economics & Outcomes Research


  • Marseille E, Kahn JG, Yazar-Klosinski BB, Doblin R. (2020) The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD. PLoS One. 15(10):e0239997


Epigenetics & Mechanistic Studies


  • Lewis, C. R., Tafur, J., Spencer, S., Green, J. M., Harrison, C., Kelmendi, B., Rabin, D. M., Yehuda, R., Yazar-Klosinski, B., & Cahn, B. R. (2023). Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD. Frontiers in Psychiatry, 14: 959590 
  • Singleton, S. P., Wang, J. B., Mithoefer, M., Hanlon, C., George, M. S., Mithoefer, A., Mithoefer, O., Coker, A. R., Yazar-Klosinski, B., Emerson, A., Doblin, R., & Kuceyeski, A. (2023). Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder. Frontiers in Psychiatry, 13: 947622 
  • Wagner MT, Mithoefer MC, Mithoefer AT, MacAulay RK, Jerome L, Yazar-Klosinski BB, Doblin R. (2017) Therapeutic effect of increased openness: Investigating mechanism of action of MDMA-assisted psychotherapy. Journal of Psychopharmacology 31(8):967-974
  • Blythe AJ, Yazar-Klosinski B, Webster MW, Chen E, Vandevenne M, Bendak K, Mackay JP, Hartzog GA, Vrielink A. (2016) The yeast transcription elongation factor Spt4/5 is a sequence-specific RNA binding protein. Protein Science. 25 (9): 1710-21


Ibogaine Clinical Development


  • Noller GE, Frampton CM, Yazar-Klosinski BB. (2017) Ibogaine Treatment Outcomes for Opioid Dependence from a Twelve-Month Follow-up Observational Study. American Journal of Drug Alcohol Abuse. 12: 1-10


LSD Clinical Development


  • Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski BB, Passie T, Brenneisen R. (2014) Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases Journal of Nervous and Mental Disease. 202 (7): 513-520


Cannabis Clinical Development


  • Bonn-Miller MO, Sisley S, Riggs P, Yazar-Klosinski B, Wang JB, Loflin MJE, Shechet B, Hennigan C, Matthews R, Emerson A, Doblin R. (2021) The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial. PLoS One. 16(3):e0246990



Copyright © 2025 Yazar Lab - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept